ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - קפסולות - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - ramucirumab - תרכיז להכנת תמיסה לאינפוזיה - ramucirumab 10 mg/ml - ramucirumab